title: [Clinical immunological disorders in children from various observation cohorts exposed to radiation factor during various stages of oncogenesis].
abstract: The immune status disorders and features depending on the radiation impact type in various cohorts of radiation observations long after the Chernobyl (CNPP) disaster and the possible role of these disorders in development of chronic somatic pathology in children are shown. Lymphocyte depletion, T-cell immunity component disorders in the form of cell contraction with CD3, CD4, CD8 markers and the B-cell immunity component disorders in the form of reducing the quantity of CD10, CD23 marker cells were observed in children subject to combined chronic irradiation by 131I, 137Cs, 90Sr radionuclides. The descendants of irradiated parents (the 1st generation; children of the Chernobyl accident consequences liquidators, children of the citizens of radiation contaminated territories with various 137Cs levels) had immunity disorders of different type. A change in the total amount of NK-cells (CD16(+)-lymphocytes) is the general sign for all radiation risk groups; however, people subject to direct radiation impact demonstrated reduction of the antitumor protection potency, whereas descendants of irradiated ones demonstrated its activation with typically increasing number of CD16(+)-lymphocytes. In all radiation risk groups, a tendency to reduction of a number of cells involved in the leukocytal activation with the "pluripotential activation" marker (CD38 marker cells), proliferating cells (CD71 marker cells) and the increase of relative amount of cells with apoptosis marker (CD95(+)-lymphocytes). Immune disorder markers under the radiation impact in various cohorts of children's observation are suggested: antigens: CD4, CD8, CD10, CD23, CD16, CD38, CB71, CD95.
authors.forename: L S
authors.initials: LS
authors.lastname: Baleva
authors.forename: I N
authors.initials: IN
authors.lastname: Iakovleva
authors.forename: A E
authors.initials: AE
authors.lastname: Sipiagina
authors.forename: N M
authors.initials: NM
authors.lastname: Karakhan
authors.forename: E E
authors.initials: EE
authors.lastname: Karpeeva
authors.forename: V M
authors.initials: VM
authors.lastname: Buiankin
authors.forename: V S
authors.initials: VS
authors.lastname: Suskova
mesh_terms: D000293:Adolescent; D041923:Adolescent Development / Q000528:radiation effects; D000328:Adult; D015703:Antigens, CD / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology / Q000528:radiation effects; D047852:Chernobyl Nuclear Accident; D002648:Child; D002657:Child Development / Q000528:radiation effects; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000528:radiation effects*; D018655:Lymphocyte Count; D008297:Male; D018811:Maternal Exposure / Q000009:adverse effects*; D018812:Paternal Exposure / Q000009:adverse effects*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000097:blood / Q000276:immunology*; D011829:Radiation Dosage; D011848:Radioactive Pollutants / Q000009:adverse effects*; D013601:T-Lymphocytes / Q000276:immunology / Q000528:radiation effects; D014455:Ukraine
chemical_list: D015703:Antigens, CD; D011848:Radioactive Pollutants